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When patients die, bereaved families may be offered
support by their local clinicians. Patients recruited into
trials are both patients and trial participants. The
B R A C E L E TS t u d yc o n s i d e r e dw h e t h e ra n yr e s p o n s ef o r
parents of babies who died after enrolment in a neonatal
intensive care (NIC) trial might be triggered by a baby’s
status as trial participant, at a bereavement follow-up
(BFU) appointment.
Thirty five clinicians and 51 bereaved parents involved
with five NIC trials were interviewed. Most clinical inter-
viewees stated they would not change their approach to
supporting parents in the BFU because a baby had been
enrolled in a trial as they believed it was not an issue par-
ents wanted to discuss, it was not relevant, and/or it was
not a topic for which relevant clinical information, such
as impact of a trial intervention, would be available.
The parents largely confirmed these views. This could
be because at the time of the BFU they did not want to
discuss trial participation; and/or did not think about
discussing trial participation.
The significance of a trial changed over time for the
majority of parents. By the time of the interviews, mostly
some years after the death, many had become more keen
to engage in questions about the research. By this time
however, they were usually no longer in contact with
either the neonatologists or the trials coordinators.
Further research is needed to consider how best to
provide longer term support for families whose relatives
died after trial participation.
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